{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:46:29Z","timestamp":1794278789308,"version":"4.9.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:p>In this study, we compared the placental T-cadherin staining intensity of pregnant women with placenta percreta (PP) and asymmetrical fetal growth restriction (FGR) compared with healthy control pregnancies. Placental T-cadherin levels of the placenta of 86 pregnant women in total, 25 with FGR, 30 with healthy pregnant subjects, and 31 with PP, were examined using monoclonal anti-T-cadherin (CDH13) antibody for immunohistochemical examination. In immunohistochemistry, <jats:italic toggle=\"yes\">H<\/jats:italic>-scores were used for each group to compare the expression of T-cadherin in extravillous trophoblast (EVT) cells. T-cadherin <jats:italic toggle=\"yes\">H<\/jats:italic>-score of EVTs was highest in the FGR group and the lowest in the PP group. The difference in <jats:italic toggle=\"yes\">H<\/jats:italic>-score between the FGR group and the control group was not statistically significant (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.344). The difference between the PP group and the other 2 groups was significant (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.0001). Multivariable linear regression analysis with a stepwise elimination method was performed in order to identify demographic and clinical parameters with significant effects on the T-cadherin <jats:italic toggle=\"yes\">H<\/jats:italic>-score of EVTs. The estimation results identified only the disease group as a significant predictor of the <jats:italic toggle=\"yes\">H<\/jats:italic>-score of EVTs (<jats:italic toggle=\"yes\">R<\/jats:italic>\n                           <jats:sup>2<\/jats:sup>=0.340, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.0001). The highest T-cadherin <jats:italic toggle=\"yes\">H<\/jats:italic>-score of EVTs was found in the FGR group and the lowest in the PP group. The low T-cadherin H-score values in the PP group suggest that low T-cadherin EVTs may be associated with increased placental invasion. Likewise, despite the statistical insignificance, a higher T-cadherin <jats:italic toggle=\"yes\">H<\/jats:italic>-score of EVTs in FGR compared with controls implies a decreased invasiveness of the placenta in FGR.<\/jats:p>","DOI":"10.1097\/pgp.0000000000000884","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T18:51:34Z","timestamp":1675363894000},"page":"293-300","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Placental T-Cadherin Correlates With Trophoblastic Invasion Anomalies: Placenta Percreta and Fetal Growth Restriction"],"prefix":"10.1097","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6111-9302","authenticated-orcid":false,"given":"Ismail","family":"Biyik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huseyin","family":"Metineren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Engin","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sercan","family":"Simsek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efser","family":"Oztas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed E.","family":"Guldur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onur","family":"Ince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,10,10]]},"reference":[{"key":"R3-20250802","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.placenta.2017.06.007","article-title":"The cytotrophoblastic shell and complications of pregnancy","volume":"60","author":"Burton","year":"2017","journal-title":"Placenta"},{"key":"R4-20250802","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/S0002-9440(10)64648-2","article-title":"A repertoire of cell cycle regulators whose expression is coordinated with human cytotrophoblast differentiation","volume":"157","author":"Genbacev","year":"2000","journal-title":"Am J Pathol"},{"key":"R5-20250802","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000359969","article-title":"Placental pathology in early-onset and late-onset fetal growth restriction","volume":"36","author":"Mifsud","year":"2014","journal-title":"Fetal Diagn Ther"},{"key":"R6-20250802","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/GRF.0000000000000392","article-title":"Pathophysiology of placenta accreta spectrum disorders: a review of current findings","volume":"61","author":"Jauniaux","year":"2018","journal-title":"Clin Obstet Gynecol"},{"key":"R7-20250802","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/scel.1993.1021","article-title":"Transmembrane control of cadherin-mediated cell-cell adhesion","volume":"4","author":"Nagafuchi","year":"1993","journal-title":"Semin Cell Biol"},{"key":"R8-20250802","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1146\/annurev.cellbio.19.011102.111135","article-title":"Cadherins as modulators of cellular phenotype","volume":"19","author":"Wheelock","year":"2003","journal-title":"Annu Rev Cell Dev Biol"},{"key":"R9-20250802","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/0955-0674(93)90029-P","article-title":"Cadherins in cancer: implications for invasion and metastasis","volume":"5","author":"Takeichi","year":"1993","journal-title":"Curr Opin Cell Biol"},{"key":"R10-20250802","first-page":"1690","article-title":"E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration","volume":"53","author":"Mayer","year":"1993","journal-title":"Cancer Res"},{"key":"R11-20250802","first-page":"3241","article-title":"Decreased E-cadherin immuno-reactivity correlates with poor survival in patients with bladder tumors","volume":"53","author":"Bringuier","year":"1993","journal-title":"Cancer Res"},{"key":"R12-20250802","first-page":"1696","article-title":"Expression of E\u2011cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis","volume":"53","author":"Oka","year":"1993","journal-title":"Cancer Res"},{"key":"R13-20250802","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0022-5347(05)66047-8","article-title":"Methylation of the E-cadherin gene promoter correlates with progression of prostate cancer","volume":"166","author":"Li","year":"2001","journal-title":"J Urol"},{"key":"R14-20250802","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3109\/14767058.2014.989203","article-title":"Trophoblastic E-cadherin and TGF-beta expression in placenta percreta and normal pregnancies","volume":"29","author":"Incebiyik","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R15-20250802","doi-asserted-by":"crossref","first-page":"499e506","DOI":"10.1007\/s00418-005-0051-7","article-title":"E-cadherin in the assessment of aberrant placental cytotrophoblast turnover in pregnancies complicated by pre-eclampsia","volume":"124","author":"Brown","year":"2005","journal-title":"Histochem Cell Biol"},{"key":"R16-20250802","doi-asserted-by":"crossref","first-page":"2649e58","DOI":"10.1083\/jcb.103.6.2649","article-title":"A novel cadherin cell adhesion molecule: its expression patterns associated with implantation and organogenesis of mouse embryos","volume":"103","author":"Nose","year":"1986","journal-title":"J Cell Biol"},{"key":"R17-20250802","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1136\/ijgc-00009577-200311000-00022","article-title":"Methylation status and expression of E-cadherin and cadherin-11 in gestational trophoblastic diseases","volume":"13","author":"Xue","year":"2003","journal-title":"Int J Gynecol Cancer"},{"key":"R18-20250802","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.cellsig.2009.01.035","article-title":"A guide and guard: the many faces of T-cadherin","volume":"21","author":"Philippova","year":"2009","journal-title":"Cell Signal"},{"key":"R19-20250802","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/uog.22134","article-title":"ISUOG Practice Guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction","volume":"56","author":"Lees","year":"2020","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R20-20250802","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ijgo.12761","article-title":"FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders","volume":"146","author":"Jauniaux","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"R21-20250802","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/humrep\/dez252","article-title":"T-cadherin inhibits invasion and migration of endometrial stromal cells in endometriosis","volume":"1","author":"Lu","year":"2020","journal-title":"Hum Reprod"},{"key":"R22-20250802","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.placenta.2010.03.002","article-title":"Cellular and molecular regulation of spiral artery remodelling: lessons from the cardiovascular field","volume":"31","author":"Whitley","year":"2010","journal-title":"Placenta"},{"key":"R23-20250802","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.placenta.2020.01.004","article-title":"Trophoblast invasion: lessons from abnormally invasive placenta (placenta accreta)","volume":"102","author":"Illsley","year":"2020","journal-title":"Placenta"},{"key":"R24-20250802","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/biolre\/ioy042","article-title":"Human trophoblast epithelial-mesenchymal transition in abnormally invasive placenta","volume":"99","author":"DaSilva-Arnold","year":"2018","journal-title":"Biol Reprod"},{"key":"R25-20250802","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1477-7827-12-7","article-title":"The term basal plate of the human placenta as a source of functional extravillous trophoblast cells","volume":"28","author":"Borbely","year":"2014","journal-title":"Reprod Biol Endocrinol"},{"key":"R26-20250802","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.placenta.2010.06.017","article-title":"Cadherins in the human placenta-epithelial-mesenchymal transition (EMT) and placental development","volume":"31","author":"Kokkinos","year":"2010","journal-title":"Placenta"},{"key":"R27-20250802","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/molehr\/6.10.943","article-title":"Localization of E-cadherin in villous, extravillous and vascular trophoblasts during intrauterine, ectopic and molar pregnancy","volume":"6","author":"Floridon","year":"2000","journal-title":"Mol Hum Reprod"},{"key":"R28-20250802","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.placenta.2015.04.001","article-title":"The invasive phenotype of placenta accreta extravillous trophoblasts associates with loss of E-cadherin","volume":"36","author":"Duzyj","year":"2015","journal-title":"Placenta"},{"key":"R29-20250802","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00404-012-2330-6","article-title":"Fetal growth restriction: current knowledge to the general Obs\/Gyn","volume":"286","author":"Nardozza","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"R30-20250802","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00001703-200104000-00011","article-title":"Antenatal assessment of the growth restricted fetus","volume":"13","author":"Baschat","year":"2001","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R31-20250802","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1113\/JP271467","article-title":"Assessment of in vivo fetal growth and placental vascular function in a novel intrauterine growth restriction model of progressive uterine artery occlusion in guinea pigs","volume":"15","author":"Herrera","year":"2016","journal-title":"J Physiol"},{"key":"R32-20250802","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajog.2010.08.009","article-title":"The \u201cGreat Obstetrical Syndromes\u201d are associated with disorders of deep placentation","volume":"204","author":"Brosens","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"R33-20250802","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.placenta.2008.04.008","article-title":"Pathophysiology of placenta creta: the role of decidua and extravillous trophoblast","volume":"29","author":"Tantbirojn","year":"2008","journal-title":"Placenta"},{"key":"R34-20250802","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0002-9378(97)70463-0","article-title":"Clinical risk factors for placenta previa-placenta accreta","volume":"177","author":"Miller","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"R35-20250802","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1136\/jcp.2008.055202","article-title":"The pathology of placenta accreta, a worldwide epidemic","volume":"61","author":"Khong","year":"2008","journal-title":"J Clin Pathol"},{"key":"R36-20250802","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/01.AOG.0000219750.79480.84","article-title":"National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Maternal morbidity associated with multiple repeat cesarean deliveries","volume":"107","author":"Silver","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R37-20250802","first-page":"44","article-title":"T-cadherin in prostate cancer: relationship with cancer progression, differentiation and drug resistance","volume":"26","author":"Dasen","year":"2016","journal-title":"J Pathol Clin Res"},{"key":"R38-20250802","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.3892\/mmr.2015.3592","article-title":"Association between the expression of T-cadherin and vascular endothelial growth factor and the prognosis of patients with gastric cancer","volume":"12","author":"Wei","year":"2015","journal-title":"Mol Med Rep"},{"key":"R39-20250802","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3109\/07357900903124472","article-title":"T-cadherin modulates tumor-associated molecules in gallbladder cancer cells","volume":"28","author":"Adachi","year":"2010","journal-title":"Cancer Invest"},{"key":"R40-20250802","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ajog.2017.11.577","article-title":"Pathophysiology of placental-derived fetal growth restriction","volume":"218","author":"Burton","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"R41-20250802","first-page":"3607","article-title":"Effect of T-cadherin on the AKT\/mTOR signaling pathway, gastric cancer cell cycle, migration and invasion, and its association with patient survival rate","volume":"17","author":"Lin","year":"2019","journal-title":"Exp Ther Med"},{"key":"R42-20250802","first-page":"38","article-title":"Overexpression of T-cadherin inhibits the proliferation of oral squamous cell carcinoma through the PI3K\/AKT\/mTOR intracellular signalling pathway","volume":"87","author":"Wang","year":"2019","journal-title":"Arch Oral Biol"},{"key":"R43-20250802","first-page":"1933719119828067","article-title":"CD97 Is decreased in preeclamptic placentas and promotes human trophoblast invasion through PI3K\/Akt\/mTOR signaling pathway","volume":"21","author":"Shen","year":"2019","journal-title":"Reprod Sci"},{"key":"R44-20250802","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.placenta.2019.08.077","article-title":"Reduced ELABELA expression attenuates trophoblast invasion through the PI3K\/AKT\/mTOR pathway in early onset preeclampsia","volume":"87","author":"Wang","year":"2019","journal-title":"Placenta"},{"key":"R45-20250802","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.placenta.2019.05.002","article-title":"Downregulation of receptor tyrosine kinase-like orphan receptor 1 in preeclampsia placenta inhibits human trophoblast cell proliferation, migration, and invasion by PI3K\/AKT\/mTOR pathway accommodation","volume":"82","author":"Chen","year":"2019","journal-title":"Placenta"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000884","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:02:40Z","timestamp":1754161360000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,10]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000000884","relation":{},"ISSN":["0277-1691"],"issn-type":[{"value":"0277-1691","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,10]]}}}